Feb 25, 2026 07:25AM
Feb 25, 2026 06:30AM
Feb 18, 2026 08:30AM
Nov 5, 2025 06:38AM
Nov 5, 2025 06:30AM
Oct 28, 2025 08:00AM
Aug 5, 2025 06:38AM Recursion Pharmaceuticals, Inc. (RXRX) Misses Q2 EPS by 6c
Aug 5, 2025 06:30AM
Jul 29, 2025 08:00AM
Jul 3, 2025 04:19AM
Jun 4, 2025 02:36PM
May 6, 2025 05:40AM
May 5, 2025 06:31AM
May 5, 2025 06:00AM Recursion Reports First Quarter 2025 Financial Results and Provides Business Update
Apr 29, 2025 08:45AM
Apr 28, 2025 08:27AM
Feb 28, 2025 06:36AM
Feb 28, 2025 06:30AM
Feb 24, 2025 08:00AM
Nov 7, 2024 04:32PM
Nov 6, 2024 04:15PM Recursion Provides Business Updates and Reports Third Quarter 2024 Financial Results
Oct 30, 2024 08:22AM
Aug 8, 2024 02:41PM
Aug 8, 2024 07:37AM
Aug 8, 2024 07:30AM
Aug 8, 2024 01:32AM
Aug 5, 2024 04:01PM
May 9, 2024 05:06PM Recursion Pharmaceuticals, Inc. (RXRX) Tops Q1 EPS by 3c
May 9, 2024 04:01PM
May 2, 2024 08:00AM
Feb 27, 2024 04:10PM
Feb 27, 2024 04:05PM
Feb 20, 2024 07:59AM
Nov 9, 2023 08:43AM
Nov 9, 2023 07:58AM Recursion Provides Business Updates and Reports Third Quarter 2023 Financial Results
Aug 8, 2023 07:58AM
May 8, 2023 08:31AM
May 8, 2023 08:14AM
Feb 27, 2023 04:30PM
Nov 8, 2022 04:30PM
Aug 9, 2022 04:15PM
Jul 21, 2022 07:55AM Recursion Pharmaceuticals (RXRX) Granted EU Orphan Drug Designation for REC-4881 for the Potential Treatment of Familial Adenomatous Polyposis
Jul 21, 2022 07:55AM
May 10, 2022 04:29PM
Apr 11, 2022 07:55AM
Apr 11, 2022 07:55AM
Mar 23, 2022 07:55AM
Mar 23, 2022 07:55AM
Mar 18, 2022 07:55AM Recursion Announces Enrollment of First Patient in Phase 2 Trial for the Treatment of Cerebral Cavernous Malformation
Dec 7, 2021 07:55AM

1,168,522 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All